期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
太仓市某医院高血压病肾损害患者中医证型与肾功能损伤程度分析
1
作者 江雪纯 范丽花 +2 位作者 尹墨青 陈赟虎 洪程 《中国医药科学》 2024年第7期104-108,共5页
目的探究太仓地区高血压病肾损害中医证型与肾功能的关系。方法纳入2021年10月至2022年10月太仓市中医医院(本院)诊治的高血压病肾损害患者363例,根据患者年龄分为青年、中年、老年三组,统计分析不同年龄段中医证型与血压水平、肾功能... 目的探究太仓地区高血压病肾损害中医证型与肾功能的关系。方法纳入2021年10月至2022年10月太仓市中医医院(本院)诊治的高血压病肾损害患者363例,根据患者年龄分为青年、中年、老年三组,统计分析不同年龄段中医证型与血压水平、肾功能损伤程度的相关性。结果太仓地区高血压病肾损害中医证型从高到低依次为脾肾两虚、肝肾阴虚、肝阳上亢、痰瘀互结,青年组以肝阳上亢型最多,中年组痰瘀互结型最少,其余各证型之间几乎持平,老年组以脾肾两虚最多,三组脾肾两虚、肝阳上亢占比比较,差异有统计学意义(P<0.05);三组痰瘀互结、肝肾阴虚占比比较,差异无统计学意义(P>0.05)。三组血压比较,差异均有统计学意义(P<0.05)。不同年龄段的肌酐、尿素氮比较,差异均有统计学意义(P<0.05),但肾小球滤过率比较,差异无统计学意义(P>0.05)。不同证型收缩压、舒张压比较,差异均有统计学意义(P<0.05),但肌酐、尿微量白蛋白、24 h蛋白尿定量比较,差异均无统计学意义(P>0.05)。结论本院高血压病肾损害以老年患者为主,证型以脾肾两虚最多,不同年龄、证型在血压、肾功能等方面均存在一定差异,临床应做到因人而异,中青年患者早诊断、早干预,以防治疾病进展,老年患者应更加关注血压、肾功能损害程度。 展开更多
关键词 高血压 肾损害 太仓地区 中医证型
下载PDF
归脾汤联合穴位贴敷降低室性早搏危险分层的临床观察
2
作者 尹墨青 范丽花 +4 位作者 江雪纯 陈赟虎 王标 张涛 徐红丰 《中医药临床杂志》 2024年第2期361-366,共6页
目的:观察归脾汤联合穴位贴敷对心脾两虚型室性早搏患者危险分层的影响。方法:选择2022年1—10月在南京中医药大学太仓附属医院心病科住院部或门诊部就诊的符合纳入标准的心脾两虚型室性早搏患者共74例作为研究对象,将其随机分为治疗组... 目的:观察归脾汤联合穴位贴敷对心脾两虚型室性早搏患者危险分层的影响。方法:选择2022年1—10月在南京中医药大学太仓附属医院心病科住院部或门诊部就诊的符合纳入标准的心脾两虚型室性早搏患者共74例作为研究对象,将其随机分为治疗组和对照组各37例。对照组给予生活方式干预及现代医学标准抗心律失常治疗,治疗组在对照组治疗基础上加用归脾汤和穴位贴敷,疗程均为8周,观察2组患者治疗前后中医证候积分及疗效、室性早搏总数、Lown分级、室早指数、室早易损指数、室性早搏QRS-T波群形态以及安全性指标的变化情况。结果:治疗后,2组中医证候总积分均明显下降,治疗组积分下降情况优于对照组;治疗组的中医证候有效率显著高于对照组;2组24h室性早搏总数均低于治疗前;治疗组Lown分级分布情况优于治疗前,且优于对照组;治疗组室早指数改善显著且优于对照组;治疗组室早易损指数改善显著且优于对照组;治疗组室早QRS-T波群形态优化情况优于对照组,差异均有统计学意义。治疗期间2组均未出现明显不良反应。结论:归脾汤联合穴位贴敷能有效改善心脾两虚型室性早搏患者的中医证候,提高疗效,降低危险分层,且安全性良好。 展开更多
关键词 归脾汤 穴位贴敷 室性早搏 心脾两虚 危险分层 中医药
下载PDF
RGV穿梭车结构与电气系统设计分析
3
作者 杨巧莉 陈云虎 +1 位作者 吴莉莉 刘尉 《智能城市应用》 2024年第2期108-110,共3页
为了降低生产车间的搬运成本并提高物料的运输效率,设计了一种新型RGV穿梭车。相较于传统RGV小车,结构上新增线头收集槽、安全卡口及阻挡器;控制系统基于高性能PLC与带位置控制功能的变频器做定位控制,根据不同对轨位置进行精确定位。... 为了降低生产车间的搬运成本并提高物料的运输效率,设计了一种新型RGV穿梭车。相较于传统RGV小车,结构上新增线头收集槽、安全卡口及阻挡器;控制系统基于高性能PLC与带位置控制功能的变频器做定位控制,根据不同对轨位置进行精确定位。此种新型RGV穿梭车已在某公司投入使用两年有余。 展开更多
关键词 RGV 结构 电气系统 PLC控制
下载PDF
心力衰竭合并利尿剂抵抗现象的中西医研究概况 被引量:4
4
作者 陈赟虎 刘学谦 高红勤 《中国中医药现代远程教育》 2022年第16期195-198,共4页
利尿剂是急慢性心力衰竭液体超负荷管理的核心。但部分心力衰竭患者不可避免出现利尿剂抵抗现象,使临床治疗处于困境,预后较差。有关利尿剂抵抗的概念、诊断标准、发病机制(病因病机)、治疗方法是当前中西医研究的热点、难点。国内外均... 利尿剂是急慢性心力衰竭液体超负荷管理的核心。但部分心力衰竭患者不可避免出现利尿剂抵抗现象,使临床治疗处于困境,预后较差。有关利尿剂抵抗的概念、诊断标准、发病机制(病因病机)、治疗方法是当前中西医研究的热点、难点。国内外均有较多的相关文献进行报道,此文立足于最新的研究报道,对心力衰竭患者合并利尿及抵抗现象的中西医相关内容进行简述。 展开更多
关键词 水肿 心力衰竭 利尿剂抵抗 中西医 综述
下载PDF
吴门医派陆继进治疗外感热病医案分析及验案赏析 被引量:1
5
作者 陈赟虎 丁烨青 高红勤 《中医临床研究》 2021年第26期31-33,共3页
以温病学说为核心内涵的吴门医派是中医学术界的重要流派,太仓吴门中医陆继进遗留的宝贵医案资料亟需整理。陆氏医案书写有特色,施治外感热病经验丰富,理法方药一线贯通,思路清晰,在学术特点上与吴门医派大家一脉相承,可谓吴门医派医家... 以温病学说为核心内涵的吴门医派是中医学术界的重要流派,太仓吴门中医陆继进遗留的宝贵医案资料亟需整理。陆氏医案书写有特色,施治外感热病经验丰富,理法方药一线贯通,思路清晰,在学术特点上与吴门医派大家一脉相承,可谓吴门医派医家之缩影。 展开更多
关键词 吴门医派 医案 温病 伏暑
下载PDF
Mirror-like tongue is an important predictor of acute heart failure:a cohort study of acute heart failure in Chinese patients
6
作者 chen yunhu YIN Moqing +4 位作者 FAN Lihua JIANG Xuechun ZHANG Tao ZHU Xingyu XU Hongfeng 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2023年第6期1243-1251,共9页
OBJECTIVE:To reveal that mirror-like tongue,observed via a noninvasive inspection,is a powerful indicator of the severity and prognosis of patients with acute heart failure(AHF).METHODS:This was an observational,prosp... OBJECTIVE:To reveal that mirror-like tongue,observed via a noninvasive inspection,is a powerful indicator of the severity and prognosis of patients with acute heart failure(AHF).METHODS:This was an observational,prospective study.A total of 408 patients who met the inclusion criteria and were diagnosed with AHF for the first time at Taicang Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine from August 2019 to January 2021 were selected as the research subjects.According to their tongue fur,the patients were divided into group A(mirror-like tongue group)and group B(non-mirror-like tongue group).The clinical characteristics and incidence of major adverse cardiovascular events(MACEs)within 1 year of follow-up were systematically compared between the two groups.RESULTS:Sixty-five patients were included in group A,and 343 patients were included in group B.There were 32 males and 33 females in group A and 168 males and 175 females in group B.The average age of the overall population was 64 years old,and the average age of group A was significantly higher than that of group B(74 vs 62 years,P<0.001).Compared with that in group B,the left ventricular ejection fraction(LVEF)in group A was significantly lower(35%vs 42%,P<0.001),and the log N-terminal pro B-type natriuretic peptide(NT-proBNP)level was significantly higher(4.0 vs 3.4,P<0.001).The proportion of the combined application of vasoactive drugs in group A was significantly higher than that in group B(64%vs 38%,P<0.001).Group B had a higher proportion of coronary angiography(29.5%vs 16.9%,P=0.038).Group A was more inclined to require mechanical ventilation than group B(33.9%vs 22.5%,P=0.049).The length of hospital stay in group A was significantly longer than that in group B(13.1 vs 7.6,P<0.001).The incidence of MACEs,such as recurrence of AHF,new myocardial infarction and stroke,in group A within one year was higher than that in group B(P=0.007,0.009,<0.001).The incidence of cumulative MACEs in group A was significantly higher than that in group B[hazard ratio=2.76,95%confidence interval(1.73,4.41),P<0.001].Univariate and multivariate Cox regression analyses showed that mirror-like tongue,age,length of stay,LVEF and log NT-proBNP were independent predictors of MACEs in patients with AHF within one year.CONCLUSIONS:Noninvasive tongue inspection technology can be used as a powerful tool for assessing the severity of illness and predicting prognosis in patients with AHF.A mirror-like tongue is an independent risk factor for MACEs in patients with AHF during the first year and has a combination effect with age,length of hospital stay,ejection fraction and NT-proBNP on the occurrence of MACEs. 展开更多
关键词 heart failure risk factors FUR Yin deficiency cohort studies
原文传递
不同抗炎药物治疗冠心病有效性和安全性的系统评价
7
作者 刘学谦 范丽花 +2 位作者 陈赟虎 陈道鹏 任翔 《中西医结合心脑血管病杂志》 2024年第15期2799-2807,共9页
目的:系统评价不同抗炎药物治疗冠心病的有效性和安全性,以进一步明确冠心病抗炎治疗的理想靶点。方法:计算机检索MedLine、the Cochrane Library、EMbase、Web of Science等数据库,检索抗炎药物治疗冠心病的随机对照试验。使用RevMan ... 目的:系统评价不同抗炎药物治疗冠心病的有效性和安全性,以进一步明确冠心病抗炎治疗的理想靶点。方法:计算机检索MedLine、the Cochrane Library、EMbase、Web of Science等数据库,检索抗炎药物治疗冠心病的随机对照试验。使用RevMan 5.3软件对纳入文献进行Meta分析。结果:纳入18篇文献,涉及65892例病人,Meta分析结果显示,接受抗炎治疗的病人发生主要不良心血管事件(MACE)的风险较低[RR=0.87,95%CI(0.79,0.96),P=0.005],亚组分析提示,白细胞介素(IL)-1拮抗剂[RR=0.87,95%CI(0.79,0.95),P=0.002]及秋水仙碱[RR=0.61,95%CI(0.48,0.79),P=0.0001]降低了病人MACE发生风险,差异有统计学意义。抗炎药物对病人全因死亡率没有影响。两组因心力衰竭再住院发生率比较,差异无统计学意义[RR=0.95,95%CI(0.83,1.10),P>0.05],亚组分析提示,IL-1拮抗剂降低了冠心病病人因心力衰竭再住院发生率[RR=0.12,95%CI(0.02,0.94),P=0.04]。不良反应方面,甲氨蝶呤增加了病人感染的风险[RR=1.13,95%CI(1.03,1.24),P=0.01]以及胃肠道不良反应的发生风险[RR=1.23,95%CI(1.07,1.43),P<0.05]。结论:现有证据表明,抗炎治疗能够减少冠心病病人MACE的发生,而核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)/IL-1/IL-6炎症通路可作为理想的治疗靶点之一。 展开更多
关键词 冠心病 抗炎药物 主要不良心血管事件 Meta分析 系统评价
下载PDF
Effectiveness of Zhuling decoction(猪苓汤) on diuretic resistance in patients with heart failure:a randomized,controlled trial 被引量:4
8
作者 chen yunhu FAN Lihua +1 位作者 ZHANG Tao LIU Xueqian 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2022年第3期439-445,共7页
OBJECTIVE:To test the effects of Zhuling decoction(猪苓汤)on patients with diuretic resistance in heart failure compared with a group of patients undergoing conventional treatment alone.METHODS:This research was a pro... OBJECTIVE:To test the effects of Zhuling decoction(猪苓汤)on patients with diuretic resistance in heart failure compared with a group of patients undergoing conventional treatment alone.METHODS:This research was a prospective,randomized,controlled study.From July 2018 to August 2020,96 diuretic resistance patients from the Cardiovascular Research Center of Taicang Hospital affiliated with Nanjing University of Traditional Chinese Medicine(GradeⅢHospital of Traditional Chinese Medicine)were enrolled in the study.The subjects were randomly divided into an observation group(48 cases)and a control group(48 cases).Patients in both groups received conventional treatment.In addition,observation group patients received Traditional Chinese Medicine Zhuling decoction.The primary endpoint was the urine output mean difference between Day 1 and Day 7 after treatment.Secondary endpoints were the changes over time in the N-terminal pro-B type natriuretic peptide(NTproBNP),New York Heart Association(NYHA)functional classification,and Minnesota Living with Heart Failure Questionnaire(MLHFQ).The safety and tolerability of the drug were comprehensively evaluated based on adverse drug reactions,as well as laboratory-assisted tests for liver and kidney function and electrolytes.RESULTS:Significant improvements were demonstrated for urine output in the two groups at Day 7,with a 1325 vs 1045 mL difference in favor of the observation group(P=0.018).The observation group also had greater improvements in NT-proBNP and NYHA functional classification changes than the control group.At the 30 th day of follow-up,a significant reduction in negative findings on the MLHFQ from baseline was observed in both groups,but the observation group demonstrated a significantly greater reduction than the control group(P<0.001).CONCLUSIONS:Zhuling decoction could be used in combination therapy for patients with diuretic resistance in heart failure in addition to standard treatment. 展开更多
关键词 heart failure diuretic resistance urine output treatment outcome Zhuling decoction randomized controlled trial
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部